Chronic Obstructive Lung Disease Clinical Trials
2 recruiting trials for Chronic Obstructive Lung Disease. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Chronic Obstructive Lung Disease clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Guy's and St Thomas' NHS Foundation Trust (1), COPD Foundation (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is No intervention (other, 1 trial), followed by Patient Reported Outcomes.
Track Chronic Obstructive Lung Disease trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
InvEstigating oeStrogen Signalling and the Effect upoN the exTracelluar Matrix In pAtients With Obstructive Lung Disease
This study aims to understand the role of oestrogen in patients with asthma and Chronic Obstructive Pulmonary Disorder (COPD). Therefore, what is the effect of oestrogen in these...
COPD Patient-Powered Research Network
The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Chronic Obstructive Lung Disease, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Chronic Obstructive Lung Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Chronic Obstructive Lung Disease, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.